Dimedone → HCID 9927530, compound
Reaction equation
[CH3:1][C:2]1([CH3:15])[CH2:13][C:12](=[O:14])[C:5]2[C:6]([C:9]([OH:11])=O)=[CH:7][O:8][C:4]=2[CH2:3]1.CC1(C)CC(=O)CC(=O)C1.[F:26][C:27]1[CH:33]=[C:32]([O:34][CH3:35])[CH:31]=[CH:30][C:28]=1[NH2:29]>>[F:26][C:27]1[CH:33]=[C:32]([O:34][CH3:35])[CH:31]=[CH:30][C:28]=1[NH:29][C:9]([C:6]1[C:5]2[C:12](=[O:14])[CH2:13][C:2]([CH3:1])([CH3:15])[CH2:3][C:4]=2[O:8][CH:7]=1)=[O:11]Participants
4
Procedure
Starting with (6,6-dimethyl-4-oxo4,5,6,7-tetrahydro-benzofuran-3-carboxylic acid), prepared from dimedone by Procedure A, and 2-fluoro-4-methoxyaniline, General Procedure B provided the title compound as a white solid:
Sources & evidence
- ORD record
- ord-a990e1af7ac54927a7051da8fffbebf2
- Source dataset
- uspto-grants-2001_07
- Patent number
- US06262272B1
Reaction notes
Loading…